Armata Pharmaceuticals, Inc. - Director's Dealing 2005

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TARGETED GENETICS CORP /WA/ (TGEN)
CIK: 0000921114
Period of Report: 2005-07-25

Reporting Person: BIOGEN IDEC INC (10% Owner)
Reporting Person: BIOGEN IDEC MA INC (10% Owner)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2005-07-25	Common Stock, $0.01 Par Value	S	8500	$.79	Disposed	11991948	Indirect
2005-07-26	Common Stock, $0.01 Par Value	S	2500	$.81	Disposed	11989448	Indirect
2005-07-26	Common Stock, $0.01 Par Value	S	12500	$.82	Disposed	11976948	Indirect
2005-07-26	Common Stock, $0.01 Par Value	S	10640	$.83	Disposed	11966308	Indirect
2005-07-26	Common Stock, $0.01 Par Value	S	11200	$.85	Disposed	11955108	Indirect
2005-07-26	Common Stock, $0.01 Par Value	S	25660	$.86	Disposed	11929448	Indirect
2005-07-26	Common Stock, $0.01 Par Value	S	2500	$.87	Disposed	11926948	Indirect

F1: Shares are owned indirectly by Biogen Idec Inc. and directly by its wholly-owned subsidiary Biogen Idec MA Inc., fka Biogen, Inc.